Report Code: A14005 | Pages: NA | Mar 2023 | 665 Views | ||
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Iron Deficiency Anemia Treatment Market
Request Now !Iron deficiency anemia is one of the most common forms of anemia that occurs when there is not enough iron in the body. Anemia is a medical condition caused by low healthy red blood cells. Red blood cells (RBCs) supply oxygen to body tissues. Iron plays an important role in making hemoglobin which is part of red blood cells. Hemoglobin deficiency indicates less oxygen in the body. Therefore, it is quite important to maintain iron levels. For the transport of oxygen, the human body needs iron. It can be prevented through the consumption of iron-rich foods such as meat, vegetables, fruits, and grains. Moreover, vitamin C also helps to prevent iron deficiency anemia. Some of the causes of iron deficiency anemia include inadequate iron intake, the inability to absorption of iron, pregnancy, and endometriosis. The symptoms of iron deficiency anemia include fatigue, tiredness, rough and dry skin, tachycardia, neurocognitive dysfunction, restless legs syndrome, difficulty breathing, or upper body discomfort.
COVID-19 Impact Analysis
Top Impacting Factors
Increase in prevalence of anemia among different groups of society, including infants, adolescents, and pregnant women contributed to the growth of the market.
In addition, certain factors are linked with the high prevalence of anemia and it includes obesity, increase in binge eating and consumption of junk foods, and rise in levels of stress are some factors which boost the market growth.
Increase in the risk of haemodilution in pregnancy drives the growth of the iron-deficiency anemia treatment market.Â
On the contrary, a rise in awareness about the treatment of anemia and an increase in investments in R&D activities to develop a novel treatment for anemia is expected to offer lucrative growth opportunities for the expansion of the market during the forecast period.
However, lack of adequate testing coupled with some adverse reactions attributed to iron supplements is one of the major factors likely to hamper the growth of the market.
Market Trends
New Product Launches to Flourish the Market
Key Benefits of the Report
Questions Answered in the Iron Deficiency Anemia Treatment Market Report
Iron Deficiency Anemia Treatment Market Report Highlights
Aspects | Details |
---|---|
By Therapy |
|
By Therapy Areas |
|
By End User |
|
By Region |
|
Key Market Players | Allergan PLC, Pharmacosmos AS, AMAG Pharmaceuticals Inc., Keryx Biopharmaceuticals Inc., Akebia Therapeutics., Sanofi Aventis,, Pieris Pharmaceuticals Inc. |
Loading Table Of Content...
Start reading.
This Report and over 19,603+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers